• Home
• About Us
• Aesthetic Medicine Training
  • Botox Training
  • Hands-On Botox and Dermal Filler Training
  • MedSpa / Aesthetic Practice Business Traininig
• Resources
  • Magazines and Periodicals and Other Links
  • More Resources
  • Associations
  • Events
  • International Aesthetic Medicine Resources
  • Archives
• Consumer Information

Subscribe

IAPAM Aesthetic Medicine Symposium with Botox Training - Sept 18-19, 2010

Presented by the IAPAM, the Aesthetic Medicine Symposium is designed by physicians for physicians who are looking to add aesthetics or medical weight management to their existing practice, open a medical spa, or work as a medical director. This is the only aesthetic medicine conference program available that combines the business and clinical aspects of incorporating aesthetic medicine procedures into your practice, along with one year unlimited practice support. Read more

               

Botox can make people feel happy

A study has revealed that Botox can make people feel happy because it stops them frowning when they are unhappy.

The anti-wrinkle drug sends back the signal to the brain reducing the intensity of the feeling.

Scientists at University of Wisconsin in the US tested 40 volunteers who had small doses of Botox into their forehead. They were then asked to read out a series of written statements ranging from ones that were “angry” to “sad” to “happy” both before and after their treatment.

Like any kind of paralysis, blocking the body’s natural movement can have an effect on emotion, said the study authors.

When those who had received the treatment read out the more negative statements they took slightly longer to do so than they had before having the injections. Read more

               

No-needle ‘Botox’ is a few years away

Revance Therapeutics says clinical trials of its no-needle Botox-like lotion will be done in about two years.

Then the FDA will decide whether to approve the drug, which is used to minimize crow’s feet, WCBS-TV reports.

“The results are good, but they probably won’t be as dramatic as [Botox] injections,” dermatologist Dr. Fredric Brandt of Miami said.
Patients tended to see a moderate reduction in wrinkles around their eyes after using RT001 — for example, a change from severe to moderate crow’s feet a month after treatment.

Dr. Richard Glogau, clinical professor of dermatology at the University of California, San Francisco, who is a primary investigator for the study, said after early trials that the Mountain View, Calif.-based company needed to rework the formulation so the drug would stay where it was applied and not spread to other parts of the body.

Source:  http://www.ocregister.com/articles/needle-258754-botox-years.html

               

Authorities Cracking Down on Fake Botox; How to Protect Yourself

Wrinkles used to be your only fleeting worry when you ponied up for Botox, but now the cost of your health could be at stake.

A surge in the number of misbranded fake versions of Botox have proliferated the market, and law enforcement officials have taken both notice and action, reports the Today Show.

In spite of the recession, Americans forked over plenty of cash for more than 2.5 million Botox injections in 2009, according to the American Society for Aesthetic Plastic Surgery.

Con artists and scammers looking to make a quick buck have since figured out how to get a hold of the main ingredient — the deadly botulinum toxin — in order to mix their own versions which they then pass off for the real thing when they sell it to sources looking to buy Botox for cheap. Read more

               

Merz Aesthetics™ Asclera™ (polidocanol) Injection Now Available in Doctors’ Offices Nationwide

Merz Aesthetics today announced it is now shipping Asclera™ (polidocanol) Injection sclerotherapy treatment to doctors’ offices throughout the U.S.  Previously only available in Europe, Asclera™ was recently approved by the U.S. Food and Drug Administration (FDA).

In a study published in the June issue of Phlebology, leading experts conclude that polidocanol is a highly effective sclerotherapy treatment.

Asclera™ was approved by the FDA on March 30 to treat uncomplicated spider veins (varicose veins less than or equal to 1 mm in diameter) and uncomplicated reticular veins (varicose veins 1 to 3 mm in diameter) in the lower extremities. It has not been studied in larger varicose veins greater than 3 mm in diameter. Once injected, it acts by damaging the cell lining of blood vessels, causing them to close and eventually disappear.

Clinical support for Asclera™ continues to grow.  In the recent Phlebology study, the authors found that polidocanol demonstrated significant efficacy over other treatment options, like sodium tetradecyl sulfate (STS) 1%. In addition, patients reported better satisfaction with polidocanol than with other treatment options. Highlights from the study include:

•The treatment success rate for polidocanol was 95% at week 12 and 95% at week 26 vs. 92% and 91% for STS, respectively; both were significantly higher than placebo (P< 0.0001).
•The majority of patients treated with polidocanol were satisfied with the treatment.
- 87% at week 12 and 84% at week 26 for patients treated with polidocanol
- 64% at week 12 and 63% at week 26 for patients treated with STS
- 14% at week 12 and 16% at week 26 for patients treated with placebo
•Treatment with polidocanol was safe and, apart from local “mild”-to-”moderate” symptoms at the injection site, well tolerated.

“The arrival of Asclera™ has been highly anticipated among physicians, with very positive initial reactions and the number of pre-orders exceeding our expectations,” said Dennis Condon, President of BioForm Medical, Inc., a Merz Aesthetics company. “We are proud to finally deliver the next level of cosmetic procedure performance that physicians and patients demand.” Read more

               

Sector Snap: Obesity drugmakers rise on study

Shares of obesity drug developers rose Thursday following a report that Arena Pharmaceuticals Inc.’s lorcaserin prompted weight loss without heart-related side effects.On Wednesday, a study showed that lorcaserin caused more people to lose at least 5 percent of their body weight over one year, or more than double the rate of placebo. The results are in Thursday’s New England Journal of Medicine.

The drug is one of three potential blockbusters that could reach the market over the next several years. A key to their success could lie in the safety profile, as prior diet pills have faced issues with heart-related problems. The drug “fen-phen” was pulled from the market in 1997 after it was tied to heart valve problems.

Shares of Arena, based in San Diego, rose 52 cents, or 12.2 percent, to $4.80 in morning trading.

Lorcaserin is set for a Food and Drug Administration review in September. Read more

               

Health Canada warns of problems with injectible wrinkle fillers

A new Health Canada report is warning of complications — including gangrene of the lip in one case — suspected of being associated with the most popular injectable wrinkle fillers on the market.

The fillers contain synthetic forms of hyaluronic acid (HA), a substance produced naturally by the body that binds with water to plump up sunken, aging skin.

According to Health Canada’s latest newsletter on adverse reaction reports, “HA dermal fillers are the most popular temporary fillers, and their use is growing.”

As of March 15, more than 30 HA dermal fillers had been licenced for sale in Canada.

As of the same date, the federal agency had received 32 reports of adverse reactions in people using those fillers. Reported reactions included pain, swelling, nodules, abscesses, pus or infection, skin discolouration, difficulty talking, swallowing or breathing and partial loss of vision, according to the article.

Some reactions persisted for weeks or months after the injection, according to Health Canada. Fifteen patients reported having had the reaction when they were injected with the fillers for the first time. Read more

               

Aesthetic Society Launches Project Beauty, NEW Consumer Website Covering All Things Beauty

 The American Society for Aesthetic Plastic Surgery (ASAPS) is proud to introduce Project Beauty, a new consumer website, that will soon become THE beauty site for consumers interested in self-improvement. Project Beauty is sponsored by one the leading medical authorities in Beauty - The American Society for Aesthetic Plastic Surgery.To kickoff the launch of Project Beauty we will host a month long giveaway contest called “30 Days of Beauty.”  Each day from July 6, 2010 – August 4, 2010, Project Beauty will offer one unique prize (prizes include a Sonicare toothbrush; a Ped Egg; a RumbaTime Watch; and cosmetics from multiple lines) per day.   All 30 prizes and the Official Sweepstakes Rules are described on the website.   Participants can score a fabulous product every day for a month.   To win people must join the Project Beauty Community, and enter daily to win the prize of the day. No purchase is necessary to enter the contest.

Project Beauty is a web.tv, video on demand website almost two years in development and extensively tested by consumers interested in plastic surgery, health and wellness topics. A video news magazine, Project Beauty is updated on a weekly basis, and features a “who’s who” list of experts on fashion, makeup, and skincare as well as news and first person stories on all things related to aesthetic surgery. Read more

               

Dermal fillers evolve

Fillers are designed to plump wrinkles, fill in hollowness and enhance lips. New kinds — including synthetic and permanent, stem cell and blood-based fillers — have recently debuted.

As women begin to notice changes to the face — fine wrinkles across the forehead, laugh lines, thinner lips and darker circles underneath the eyes — they often look for help to combat these first signs of aging. Over-the-counter creams are limited in their effectiveness, and plastic surgery may be too extreme a response, but dermal fillers offer an attractive solution: immediate, subtle results that can last from several months to a year or more.

“A very animated, expressive individual will develop lines much sooner,” says Beverly Hills dermatologist, Dr. Nathan Newman. “Botox and fillers are a good way to prevent the lines caused by these expressions from becoming deep creases.”

Dermal fillers are often confused with Botox, and though both are delivered by injection, they serve very different purposes. As the name implies, fillers are designed to plump wrinkles, fill in hollowness and enhance lips, while Botox targets and relaxes muscles to prevent new lines from developing.

The advantages of fillers outweigh the risks, according to experts such as Dr. Neal Schultz of DermTV.com. Fillers are generally cost-effective (starting at a few hundred dollars), easy to administer and natural looking. Schultz says. The effects generally last four to 12 months. The risks? Fillers can cause occasional bruising, mild pain or discomfort when injected and, in rare circumstances, allergic reactions.

Increasingly popular, brand-named fillers can be classified into several categories: collagen, hyaluronic acid (Juvaderm and Restylane), calcium-based (Radiesse) and poly-L-lactic acid (Sculptra). However, new kinds of fillers — including synthetic and permanent options, stem cell and blood-based fillers — have recently debuted on the market, making it even harder to evaluate the growing list of brands. Read more

               

Migrane Cure Approved Using Botox

UK drug regulators have approved the use of botox to cure migraines.

The approval comes after a trial of more than 1,300 people showed that it was successful in reducing the amount of headaches suffered.

However the approval will only affect those people who suffer more than 15 migraines per month according to the Medicines and Healthcare Products Regulatory Agency.

Exact mechanics of how botox works are unknown but are thought to relax the muscles and block pain signals to the areas it is applied to.

The UK sees an estimated 700,000 people suffering from migraines and charities have previously been concerned that more chronic migraines are not diagnosed properly leaving sufferers struggling to find any effective treatments or remedies.

In clinical trials, patients were given up to five courses of injections of botox into specific head and neck muscles every 12 weeks. Read more

               

Next Page »

IAPAM Aesthetic Medicine Resources

• Recent News

  • Oral supplements enhance effects of botox
  • Allergan Pleads Guilty, Settles Botox Investigation
  • Allergan Resolves United States Government Investigation of Past Sales and Marketing Practices Relating to Certain Therapeutic Uses of BOTOX
  • Pay Growing Faster for Nurse Practitioners Than Physicians
  • Membership in the IAPAM Helps Physicians Profitably Enter Aesthetic Medicine
  • Drinking Water Proven to Help Weight Loss
  • Botox Reduces Pain From Postmastectomy Reconstruction
  • New Non-Surgical Techniques for Volume Enhancement and Loose Skin Help Rejuvenate the Aging Face
  • Protect skin from sun damage: Educate patients
  • Cosmetic facial filler suspended in the EU

Copyright © 2010 Aesthetic Medicine News · Sitemap · Privacy Policy & Terms of Use · Login